Sequential implementation of DSC-MR perfusion and dynamic [(18)F]FET PET allows efficient differentiation of glioma progression from treatment-related changes

PURPOSE: Perfusion-weighted MRI (PWI) and O-(2-[(18)F]fluoroethyl-)-l-tyrosine ([(18)F]FET) PET are both applied to discriminate tumor progression (TP) from treatment-related changes (TRC) in patients with suspected recurrent glioma. While the combination of both methods has been reported to improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Steidl, Eike, Langen, Karl-Josef, Hmeidan, Sarah Abu, Polomac, Nenad, Filss, Christian P., Galldiks, Norbert, Lohmann, Philipp, Keil, Fee, Filipski, Katharina, Mottaghy, Felix M., Shah, Nadim Jon, Steinbach, Joachim P., Hattingen, Elke, Maurer, Gabriele D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113145/
https://www.ncbi.nlm.nih.gov/pubmed/33241456
http://dx.doi.org/10.1007/s00259-020-05114-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113145/
https://www.ncbi.nlm.nih.gov/pubmed/33241456
http://dx.doi.org/10.1007/s00259-020-05114-0

Ejemplares similares